Skip to main content

Advertisement

Log in

Inhibition of heat-induced denaturation of albumin by nonsteroidal antiinflammatory drugs (NSAIDs): Pharmacological implications

  • Research Articles
  • Pharmacology, Toxicology & Pharmaceutics
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

The activity of nonsteroidal antiinflammatory drugs (NSAIDs) in rheumatoid arthritis is not only due to the inhibition of the production of prostaglandins, which can even have beneficial immunosuppressive effects in chronic inflammatory processes. Since we speculated that these drugs could also act by protecting endogenous proteins against denaturation, we evaluated their effect on heat-induced denaturation human serum albumin (HSA) in comparison with several fatty acids which are known to be potent stabilizers of this protein. By the Mizushimas assay and a recently developed HPLC assay, we observed that NSAIDs were slightly less active [EC50∼10−5-10−4 M] than FA and that the HPLC method was less sensitive but more selective than the turbidimetric assay, i.e. it was capable of distinguishing true antiaggregant agents like FA and NSAIDs from substances capable of inhibiting the precipitation of denatured protein aggregates. In conclusion, this survey could be useful for the development of more effective agents in protein condensation diseases like rheumatic disorders, cataract and Alzheimers disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Abramson, S. B. and Weissmann, G., The mechanisms of action of nonsteroidal antiinflammatory drugs.Arthritis Rheum., 32, 1–9 (1989).

    Article  PubMed  CAS  Google Scholar 

  • Abramson, S. B., Mechanisms of action of nonsteroidal anti-inflammatory drugs and therapeutic considerations.Bull. Hosp. Jt. Dis. Orthop. Inst., 50, 107–15 (1990).

    PubMed  CAS  Google Scholar 

  • Abramson, S. B., Therapy with and mechanisms of nonsteroidal anti-inflammatory drugs.Curr. Opin. Rheumatol., 3, 336–40 (1991).

    Article  PubMed  CAS  Google Scholar 

  • Ballou, G. A., Boyer, P. D., Luck, J. M., and Lum, F. G., The heat coagulation of human serum albumin.J. Biol. Chem., 153, 589–605 (1944).

    CAS  Google Scholar 

  • Benedek, G. B., Cataract as a protein condensation disease: the Proctor Lecture.Invest. Ophthalmol. Vis. Sci., 38, 1911–1921 (1997).

    PubMed  CAS  Google Scholar 

  • Bertelli, A. and Silvestrini, B., Current trends in the research on antiinflammatory agents.Int. J. Tissue. React., 7, 169–173 (1985).

    PubMed  CAS  Google Scholar 

  • Boyer, P. D., Lum, F. G., Ballou, G. A., Luck, J. M., and Rice, R. G., The combination of fatty acids and related compounds with serum albumin.J. Biol. Chem., 162, 181–98 (1946).

    CAS  Google Scholar 

  • Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal. Biochem., 72, 248–254 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Bruno, M. R., Sensi, M., Cioccia, G. P., Valente, L., Negri M., Ghirlanda, G. and Pozzilli, P., Inhibition of protein non-enzymic glycation induced by Bendazac.Diabetes Res., 9, 11–14 (1988).

    PubMed  CAS  Google Scholar 

  • Carter, D. C. and Ho, J. X., Structure of serum albumin.Adv. Protein Chem., 45, 153–203 (1994).

    Article  PubMed  CAS  Google Scholar 

  • Chen, R. F., Removal of fatty acids from serum albumin by charcoal treatment.J. Biol. Chem., 242, 173–181 (1967).

    PubMed  CAS  Google Scholar 

  • Cheng, C. Y., Mathur, P. P. and Grima, J., Structural analysis of clusterin and its subunits in ram rete testis fluid.Biochemistry, 27, 4079–4088 (1988).

    Article  PubMed  CAS  Google Scholar 

  • Cherian, M. and Abraham, E. C., Glycation of human lens crystallins: effect of age and aspirin treatment.Ophthalmic Res., 25, 349–354 (1993).

    Article  PubMed  CAS  Google Scholar 

  • Cioli, V., Ciarniello, M. G., Guglielmotti, A., Luparini, M. R. Durando, L., Martinelli, B., Catanese, B., Fava, L., and Silvestrini, B., A new protein antidenaturant agent, bindarit, reduces secondary phase of adjuvant arthritis in rats.J. Rheumatol., 19, 1735–1742 (1992).

    PubMed  CAS  Google Scholar 

  • Cioli, V., Corradino, C. and Scorza Barcellona P., Review of pharmacological data on benzydamine.Int. J. Tissue React., 7, 205–213 (1985).

    PubMed  CAS  Google Scholar 

  • Colaco, C. A., Ledesma, M. D., Harrington, C. R., and Avila, J., The role of the Maillard reaction in other pathologies: Alzheimer's disease.Nephrol Dial Transplant 11 (Suppl 5), 7–12 (1996).

    PubMed  CAS  Google Scholar 

  • Diaz-Gonzalez, F. and Sanchez-Madrid, F., Inhibition of leukocyte adhesion: an alternative mechanism of action for anti-inflammatory drugs.Immunol Today, 1998 Apr; 19(4): 169–72.

    Article  PubMed  CAS  Google Scholar 

  • Gomes, I., Aspirin: a neuroprotective agent at high doses?Natl. Med. J. India., 11, 14–17 (1998).

    PubMed  CAS  Google Scholar 

  • Goodwin, J. S., Immunologic effects of nonsteroidal anti-inflammatory drugs.Am. J. Med., 77, 7–15 (1984b).

    Article  PubMed  CAS  Google Scholar 

  • Goodwin, J. S., Mechanism of action of nonsteroidal anti-inflammatory agents.Am. J. Med., 77, 57–64 (1984a).

    PubMed  CAS  Google Scholar 

  • Harding, J. J., Pharmacological treatment strategies in age-related cataracts.Drug Aging, 2, 287–300 (1992).

    Article  CAS  Google Scholar 

  • Insel, P. A., Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. In The pharmacological Basis of Therapeutics, Edited by Hardman JG, Limbird LE, Molinoff PB, Ruddon RW and Goodman Gilman A, pp 617–657, McGraw Hill, New York (1996).

    Google Scholar 

  • Kremer, J. M., Effects of modulation of inflammatory and immune parameters in patients with rheumatic and inflammatory disease receiving dietary supplementation of n-3 and n-6 fatty acids.Lipids, 31, S243-S247 (1996).

    Article  PubMed  CAS  Google Scholar 

  • Laemmli, U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4.Nature, 227, 680–685 (1970).

    Article  PubMed  CAS  Google Scholar 

  • Macart, M. and Gerbaut, L., An improvement of the Coomassie Blue dye binding method allowing an equal sensitivity to various proteins: application to cerebrospinal fluid.Clin. Chim. Acta., 122, 93–101 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Marques, C., Ramalho, J. S., Pereira, P. and Mota, M. C., Bendazac decreases in vitro glycation of human lens crystallins. Decrease of in vitro protein glycation by bendazac.Doc. Ophthalmol., 90, 395–404 (1995).

    Article  PubMed  CAS  Google Scholar 

  • Mizushima, Y. and Suzuki, H., Interaction between plasma proteins and antirheumatic or new antiphlogistic drugs.Arch. Intern. Pharmacodyn., 157, 115–124 (1965).

    CAS  Google Scholar 

  • Mizushima, Y., Inhibition of protein denaturation by anti-rheumatic or antiphlogistic agents.Arch. Int. Pharmacodyn., 149, 1–7 (1964).

    PubMed  CAS  Google Scholar 

  • Nargund, L. V., Reddy, G. R. and Hariprasad, V., Anti-inflammatory activity of substituted 1,3,4-oxadiazoles.J. Pharm. Sci., 83, 246–248 (1994).

    Article  PubMed  CAS  Google Scholar 

  • Peters, T., Serum albumin.Adv. Prot. Chem., 37, 161–245 (1985).

    Article  CAS  Google Scholar 

  • Roberts, K. A. and Harding, J. J., Ibuprofen, a putative anti-cataract drug, protects the lens against cyanate and galactose.Exp. Eye. Res., 50, 157–164 (1990).

    Article  PubMed  CAS  Google Scholar 

  • Rogers, J., Kirby, L. C., Hempelman, S. R., Berry, D. L., McGeer, P. L., Kaszniak, A. W., Zalinski, J., Cofield, M., Mansukhani, L. and Willson, P.,et al.: Clinical trial of indomethacin in Alzheimer's disease.Neurology, 43, 1609–1611 (1993).

    PubMed  CAS  Google Scholar 

  • Saso, L., Casini, M. L., Valentini, G., Mattei, E., Panzironi, C., and Silvestrini, B., Development of an HPLC assay to study the effect of endogenous and exogenous substances on heat-induced aggregation of human serum albumin.Clin. Chem. Lab. Med., 36, 155–162 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Saso, L., Silvestrini, B., Guglielmotti, A., Lahita, R., and Cheng, C. Y., Abnormal glycosylation of α2-macroglobulin, a non-acute-phase protein, in patients with auto-immune diseases.Inflammation, 17, 465–479 (1993b).

    Article  PubMed  CAS  Google Scholar 

  • Saso, L., Silvestrini, B., Lahita, R. and Cheng, C. Y., Changes of immunoreactivity in α1-antitrypsin in patients with autoimmune diseases.Inflammation, 17, 383–400 (1993a).

    Article  PubMed  CAS  Google Scholar 

  • Saso, L., Silvestrini, B., Zwain, I., Guglielmotti, A., Luparini, M. R., Cioli, V. and Cheng, C. Y., Abnormal glycosylation of hemopexin in arthritic rats can be blocked by bindarit.J. Rheumatol., 19, 1859–1867. (1992).

    PubMed  CAS  Google Scholar 

  • Saso, L., Valentini, G., Casini, M. L., Mattei, E., Braghiroli, L., Mazzanti, G., Panzironi, C., Grippa, E., and Silvestrini, B., Inhibition of protein denaturation by fatty acids, bile salts and other natural substances: a new hypothesis for the mechanism of action of fish oil in rheumatic diseases.Jpn. J. Pharmacol., 79, (in press) (1999).

  • Silvestrini, B., Catanese, B., Lisciani, R. and Alessandroni, A., Studies on the mechanism of action of bendazac (AF-983).Arzneim. Forsch., 20, 250–253 (1970).

    CAS  Google Scholar 

  • Silvestrini, B., Cioli, V. and Burberi, S., Pharmacological properties of bendazac (AF-983), with particular reference to its topical action on some experimental inflammatory processes.Arzneim. Forsch., 19, 30–36 (1969).

    CAS  Google Scholar 

  • Silvestrini, B., Guglielmotti, A., Saso, L. and Cheng, C. Y., Changes in concanavalin A-reactive proteins in inflammatory disorders.Clin. Chem., 35, 2207–2211 (1989).

    PubMed  CAS  Google Scholar 

  • Silvestrini, B., Primary and secondary inflammation.Panminerva. Med., 11, 587–593 (1969).

    Google Scholar 

  • Silvestrini, B., Rationale for bendazac: In Recent Developments in the Pharmacological Treatment of Cataract, Edited by Dermo F, Ponte F And Laties AM, pp 1–9, Kugler, Amsterdam (1987).

    Google Scholar 

  • Stevens, A., The contribution of glycation to cataract formation in diabetes.J. Am. Optom. Assoc., 69, 519–30 (1998).

    PubMed  CAS  Google Scholar 

  • Swamy, M. S. and Abraham, E. C., Inhibition of lens crystallin glycation and high molecular weight aggregate formation by aspirinin vitro andin vivo.Invest. Ophthalmol. Vis. Sci., 30, 1120–6 (1989).

    PubMed  CAS  Google Scholar 

  • Tallarida, R. J. and Murray, R. B., Manual of Pharmacologic Calculations with Computer Programs. New York, Springer-Verlag, (1986).

    Google Scholar 

  • van der Tempel, H., Tulleken, J. E., Limburg, P. C., Muskiet, F. A. and van Rijswijk, M. H., Effects of fish oil supplementation in rheumatoid arthritis.Ann. Rheum. Dis., 49, 76–80 (1990).

    Article  PubMed  Google Scholar 

  • Vane, J. R., Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.Nature (New Biol), 231, 232–235 (1971).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luciano Saso.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saso, L., Valentini, G., Casini, M.L. et al. Inhibition of heat-induced denaturation of albumin by nonsteroidal antiinflammatory drugs (NSAIDs): Pharmacological implications. Arch. Pharm. Res. 24, 150–158 (2001). https://doi.org/10.1007/BF02976483

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02976483

Key words

Navigation